Cocrystal Pharma, Inc.
Data quality: 83%
COCP
Nasdaq
Manufacturing
Chemicals
$1.46
▲
$0.02
(1.39%)
Mkt Cap: 20.13 M
Price
$1.46
Mkt Cap
20.13 M
Day Range
$1.36 — $1.52
52-Week Range
$0.86 — $2.67
Volume
498,858
Open $1.40
50D / 200D Avg
$1.03
41.17% above
50D / 200D Avg
$1.23
18.86% above
Quick Summary
Key Takeaways
Negative free cash flow of -8.20 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-135.84%
Below sector avg (-53.47%)
ROIC-91.35%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio5.78
Interest Coverage-67.31
Valuation
PE (TTM)
-2.28
Below sector avg (-1.47)
P/B Ratio2.62
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.3 | -1.5 |
| P/B | 2.6 | 1.6 |
| ROE % | -135.8 | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -8.83 M |
| ROE | -135.84% | ROA | -93.20% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -8.20 M |
| ROIC | -91.35% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 5.78 |
| Interest Coverage | -67.31 | Asset Turnover | N/A |
| Working Capital | 7.26 M | Tangible Book Value | 7.67 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.28 | Forward P/E | N/A |
| P/B Ratio | 2.62 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -40.76% | ||
| Market Cap | 20.13 M | Enterprise Value | 20.13 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.78 | Revenue / Share | N/A |
| FCF / Share | -0.60 | OCF / Share | -0.59 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 92.90% |
| SBC-Adj. FCF | -8.67 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 2.01 M |
| Net Income | -8.83 M | -17.50 M | -17.98 M | -38.84 M | -14.19 M |
| EPS (Diluted) | -0.78 | -1.72 | -1.87 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -9.02 M | -17.88 M | -18.56 M | -38.83 M | -14.22 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5.06 M | 12.54 M | 15.17 M | 12.39 M | 8.79 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 72,000.0 | 126,000.0 | 189,000.0 | 185,000.0 | 190,000.0 |
| Interest Expense | -134,000.0 | -537,000.0 | -640,000.0 | 2,000.0 | 4,000.0 |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9.71 M | 13.46 M | 31.26 M | 40.84 M | 79.39 M |
| Total Liabilities | 3.38 M | 3.93 M | 4.88 M | 1.27 M | 1.84 M |
| Shareholders' Equity | 6.33 M | 9.52 M | 26.38 M | 39.57 M | 77.55 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 7.03 M | 9.86 M | 26.35 M | 37.22 M | 58.71 M |
| Current Assets | 8.13 M | 11.58 M | 29.09 M | 40.18 M | 59.32 M |
| Current Liabilities | 2.21 M | 2.43 M | 3.26 M | 1.22 M | 1.55 M |
{"event":"ticker_viewed","properties":{"ticker":"COCP","listing_kind":"stock","pathname":"/stocks/cocp","exchange":"Nasdaq","country":"US"}}